The US Food and Drug Administration (FDA) has released a statement about the agency’s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk. The ISCT Global Government and Public Relations Committee supports the FDA’s ongoing commitment to helping advance legitimate stem cell therapy development under existing agency regulations.
Read Statement »
#News